Relationship Graph Explorer
Follow the connections
Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.
🌿
Herb
6,826
→
⚗️
Ingredient
44,595
→
🧬
Gene Target
15,505
→
🏥
Disease
30,170
→
🧪
Evidence
23,295
trials · metas · refs
Plus 6,743 TCM formulas connecting herbs together
🏥 Disease / Health Topic
Adenosquamous Cell Lung Cancer
3
Clinical Trials
0
Meta-Analyses
0
PubMed References
📋 Sample Trials
NCT00368992
S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer
Completed · Phase 2
NCT00387374
Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by Bevacizumab
Completed · Phase 2
NCT00040794
Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer
Completed · Phase 2
📊 Sample Meta-Analyses
None linked yet.
📚 Sample References
None linked yet.
🏥 All Disease / Health Topic data fields for Adenosquamous Cell Lung Cancer
🏥 Names
Disease Name
Adenosquamous Cell Lung Cancer
Alias Names
Adenosquamous Lung Carcinoma
Topic Type
disease
🧬 Ontology Classifications
DisGeNET Type
disease
UMLS Type
Neoplastic Process
MeSH Class
Respiratory Tract Diseases; Neoplasms
DO Class
disease of anatomical entity; disease of cellular proliferation
🔗 External References
🔍 Raw view — every non-empty column on this row (25 fields)
name
Adenosquamous Cell Lung Cancer
alias name
Adenosquamous Lung Carcinoma
topic type
disease
disgenet disease type
disease
umls disease type
Neoplastic Process
mesh disease class
Respiratory Tract Diseases; Neoplasms
do disease class
disease of anatomical entity; disease of cellular proliferation
umls disease type id
T191
mesh disease class id
C04; C08
do disease class id
DOID:14566; DOID:7
herb disease id
HBDIS007071
disgenet id
C0279557
do id
4829
⚗️ Related Ingredients
1 · shared evidence📋 Clinical Trials
3 · subject of clinical studyNCT00368992 S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients
→ Adenocarcinoma of the Lung|Adenosquamous Cell Lung
NCT00387374 Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients
→ Adenosquamous Cell Lung Cancer|Drug/Agent Toxicity
NCT00040794 Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients
→ Adenocarcinoma of the Lung|Adenosquamous Cell Lung
How relationships are computed
- Clinical Trials / Meta-Analyses / References: direct foreign-key link via
subject_entity_id(Phase 2d wireup) - Formula ↔ Herbs: text bridge via
formulas.herbs_in_pinyinmatchingherbs.pinyin_name - Herb ↔ Ingredient:
empty — needs
HERB_herb_ingredientimport - Ingredient ↔ Target:
empty — needs
HERB_ingredient_targetimport - Target ↔ Disease:
empty — needs
HERB_target_diseaseimport - Herb → Target → Disease (full chemical spine): awaiting Phase 2e link tables